Pharmacological Practice for One Case of Advanced Lung Cancer with Bronchial Asthma and Pulmonary Infection

Abstract

Abstract: Objective To explore the role of clinical pharmacists in the treatment of patients with advanced lung cancer and bronchial asthma. Methods Based on one case of advanced lung cancer with severe pain and bronchial asthma, the clinical pharmacists carried out pharmaceutical care from analgesic drugs selection and evaluation, adverse reactions precaution and anti-infection drugs choice etc. Results The clinical pharmacist proposed individualized treatment, and the doctor adopted the recommendation to ensure the patient's safe use of medication, and improved the quality of life and the level of clinical drug treatment. Conclusion The collaboration of clinical pharmacists and clinicians is benefit to optimize patients' individualized treatment regimens and ensure the safety and effect of drugs from drug selection, contraindication, adverse reaction prevention etc.

Key words: lung cancer, cancer pain, asthma, clinical pharmacists, pharmaceutical care

CLC Number:

CAI Jiangxia, AN Linna. Pharmacological Practice for One Case of Advanced Lung Cancer with Bronchial Asthma and Pulmonary Infection[J]. Chinese Journal of Pharmacovigilance, 2019, 16(8): 492-495.

References

[1] 陈万青, 张思维, 曾红梅, 等. 中国2010年恶性肿瘤发病率和死亡[J]. 中国肿瘤, 2014, 23(1): 1-10.
[2] 徐丽. 癌痛管理中规范化临床药学服务模式的建立及应用[J]. 临床合理用药杂志, 2019, 12(8): 96-97.
[3] 纪京绪, 杜彩云. 阶梯性镇痛护理对恶性肿瘤患者负性情绪、疼痛状况的影响[J]. 实用临床医药杂志, 2019, 23(4): 129-132.
[4] 贾继媛. 规范化癌痛护理对癌痛患者心理状态、疼痛程度及服药依从性的影响[J]. 中国民康医学, 2019, 31(3): 170-172.
[5] 俞丽华, 刘孟娟, 王增. 阿片类癌痛治疗药物制剂的研究进展[J]. 中国药物警戒, 2014, 11(1): 19-22.
[6] National Comprehensive Cancer Network( NCCN). NCCN clinical practice guidelines in Oncology: Adult Cancer Pain (Version 2. 2019) [EB/OL]. (2019-03-15)[2019-06-11]. http://guide.medlive.cn/guideline/17684.
[7] 吕小东. 支气管哮喘防治指南(2016年版)[J]. 中华结核和呼吸杂志, 2016, 39(9):675-697.
[8] Temel J S, Pirl W F, Lynch T J.Comprehensive symptom management in patients with advanced-stage non-small-cell lung cancer[J]. Clin Lung Cancer, 2006, 7(4):241-249.
[9] Yamaguchi T, Goya S, Kohara H, et al.Treatment Recommendations for Respiratory Symptoms in Cancer Patients: Clinical Guidelines from the Japanese Society for Palliative Medicine[J]. J Palliat Med, 2016, 19(9):925-935.
[10] Kloke M, Cherny N.Treatment of dyspnoea in advanced cancer patients: ESMO Clinical Practice Guidelines[J]. Annals of Oncology, 2015, 26(suppl 5):v169-v173.
[11] 呼吸困难诊断、评估与处理的专家共识组. 呼吸困难诊断、评估与处理的专家共识[J]. 中华内科杂志, 2014, 53(4):337-341.
[12] Parshall M B, Schwartzstein R M, Adams L, et al.An Official American Thoracic Society Statement: Update on the Mechanisms, Assessment, and Management of Dyspnea[J]. Am J Respir Crit Care Med, 2011, 185(4):435-452.
[13] Temel J S, Pirl W F, Lynch T J.Comprehensive symptom management in patients with advanced-stage non-small-cell lung cancer[J]. Clin Lung Cancer, 2006, 7(4):241-249.
[14] Currow D C, McDonald C, Oaten S, et al. Once-daily opioids for chronic dyspnea: a dose increment and pharmac-ovigilance study[J]. J Pain Symptom Manage, 2011, 42(3): 388-399.
[15] Johnson H, Paulozzi L, Porucznik C, et al.Decline in drug overdose deaths after state policy changes-Florida, 2010-2012[J]. Mmwr Morbid Mortal Weekly Report, 2014, 63(26):569.
[16] Zacny J P, Paice J A, Coalson D W.Separate and combined psychopharmacological effects of alprazolam and oxycodone in healthy volunteers[J]. Drug Alcohol Depen, 2012, 124(3):274-282.
[17] Jann M, Kennedy W K, Lopez G.Benzodiazepines: a major component in unintentional prescription drug overdoses with opioid analgesics[J]. J Pharm Pract, 2014, 27(1):5-16.
[18] Dublin S, Walker R L, Jackson M L, et al.Use of Opioids or Benzodiazepines and Risk of Pneumonia in Older Adults: A Population-Based Case-Control Study[J]. J Am Geriatr Soc, 2011, 59(10): 1899-1907.